{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:31:07Z","timestamp":1790947867994,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CMU112-S-06"],"award-info":[{"award-number":["CMU112-S-06"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-114-185"],"award-info":[{"award-number":["DMR-114-185"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012544","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012544","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 11 4 -2314-B-384-0 08 -"],"award-info":[{"award-number":["NSTC 11 4 -2314-B-384-0 08 -"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-039-058"],"award-info":[{"award-number":["NSTC 112-2314-B-039-058"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejphar.2025.178205","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:31:08Z","timestamp":1759282268000},"page":"178205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Spinal blockade with intrathecal spiradoline and buprenorphine in rats"],"prefix":"10.1016","volume":"1006","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-0245","authenticated-orcid":false,"given":"An-Kuo","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Chi","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7560-2127","authenticated-orcid":false,"given":"Yu-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-4342","authenticated-orcid":false,"given":"Ching-Hsia","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhi-Joung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178205_bib1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/00000539-200012000-00038","article-title":"Block of neuronal tetrodotoxin-resistant Na+ currents by stereoisomers of piperidine local anesthetics","volume":"91","author":"Brau","year":"2000","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2025.178205_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pain.2004.08.003","article-title":"Intrathecal tri-cyclic antidepressants produce spinal anesthesia","volume":"112","author":"Chen","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2025.178205_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.70003","article-title":"Adrenaline enhances nociceptive and motor blockades by intrathecal carteolol and oxprenolol in rats","volume":"39","author":"Chiu","year":"2025","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178205_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jphp.12894","article-title":"Intrathecal pramoxine causes long-lasting spinal sensory and motor block in rats","volume":"70","author":"Chou","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178205_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.37796\/2211-8039.1425","article-title":"Hematological biomarkers of troponin, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio serve as effective predictive indicators of high-risk mortality in acute coronary syndrome","volume":"13","author":"de Liyis","year":"2023","journal-title":"Biomedicine"},{"key":"10.1016\/j.ejphar.2025.178205_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/cvr\/25.10.802","article-title":"Inhibitory effect of spiradoline, a kappa opioid receptor agonist, on Ca2+ induced contraction and the intracellular Ca2+ concentration in porcine coronary artery","volume":"25","author":"Harasawa","year":"1991","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178205_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AAP.0b013e318274a8a1","article-title":"The kappa-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons","volume":"38","author":"Hassan","year":"2013","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.ejphar.2025.178205_bib8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bph.12796","article-title":"BU08073 a buprenorphine analogue with partial agonist activity at mu-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice","volume":"172","author":"Khroyan","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178205_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837088","article-title":"Sodium channels and local anesthetics-old friends with new perspectives","volume":"13","author":"Korner","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178205_bib10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e3182557917","article-title":"Local anesthetic-like inhibition of voltage-gated Na(+) channels by the partial mu-opioid receptor agonist buprenorphine","volume":"116","author":"Leffler","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2025.178205_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FBP.0000000000000184","article-title":"Additive antinociceptive effects of mixtures of the kappa-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats","volume":"27","author":"Maguire","year":"2016","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178205_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/jpet.116.235630","article-title":"Behavioral characterization of kappa opioid receptor agonist spiradoline and cannabinoid receptor agonist CP55940 mixtures in rats","volume":"360","author":"Minervini","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178205_bib13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.0006-341X.1999.01030.x","article-title":"Likelihood-based experimental design for estimation of ED50","volume":"55","author":"Minkin","year":"1999","journal-title":"Biometrics"},{"key":"10.1016\/j.ejphar.2025.178205_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.coms.2021.08.003","article-title":"Updates on topical and local anesthesia agents","volume":"34","author":"Mundiya","year":"2022","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"10.1016\/j.ejphar.2025.178205_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.anclin.2023.11.011","article-title":"Local anesthetics, local anesthetic systemic toxicity (LAST), and liposomal bupivacaine","volume":"42","author":"On'Gele","year":"2024","journal-title":"Anesthesiol. Clin."},{"key":"10.1016\/j.ejphar.2025.178205_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/JPR.S211234","article-title":"Continuous wound infiltration of local anesthetics in postoperative pain management: safety, efficacy and current perspectives","volume":"13","author":"Paladini","year":"2020","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejphar.2025.178205_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-3565(25)22683-0","article-title":"Diuretic actions in man of a selective kappa opioid agonist: U-62,066E","volume":"240","author":"Peters","year":"1987","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178205_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0022-3565(25)20714-5","article-title":"Spinal analgesic actions of kappa receptor agonists, U-50488H and spiradoline (U-62066)","volume":"251","author":"Piercey","year":"1989","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178205_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00005344-199812000-00002","article-title":"Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat","volume":"32","author":"Pugsley","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178205_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0306-3623(01)00079-9","article-title":"Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes","volume":"34","author":"Pugsley","year":"2000","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178205_bib21","first-page":"61","article-title":"Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist","volume":"6","author":"Pugsley","year":"2001","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.ejphar.2025.178205_bib22","first-page":"37","article-title":"The influence of the kappa agonist-spiradoline (U62066E) on the analgesic activity of some opioids at the spinal level","volume":"46","author":"Stachura","year":"1994","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178205_bib23","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/AAP.0000000000000596","article-title":"Inhibition of voltage-gated Na+ channels by bupivacaine is enhanced by the adjuvants buprenorphine, ketamine, and clonidine","volume":"42","author":"Stoetzer","year":"2017","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.ejphar.2025.178205_bib24","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1152\/jn.00624.2001","article-title":"Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects","volume":"87","author":"Su","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2025.178205_bib25","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1021\/jm00352a005","article-title":"Benzeneacetamide amines: structurally novel non-m mu opioids","volume":"25","author":"Szmuszkovicz","year":"1982","journal-title":"J. Med. Chem."},{"issue":"PL","key":"10.1016\/j.ejphar.2025.178205_bib26","first-page":"23","article-title":"Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram","volume":"58","author":"Tallarida","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.178205_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(25)33422-1","article-title":"U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist","volume":"224","author":"Vonvoigtlander","year":"1983","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178205_bib28","article-title":"Buprenorphine reduces methamphetamine intake and drug seeking behavior via activating nociceptin\/orphanin FQ peptide receptor in rats","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Psychiatr."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925009598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T04:27:53Z","timestamp":1780201673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925009598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S0014299925009598"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178205","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spinal blockade with intrathecal spiradoline and buprenorphine in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178205"}}